Health & Fitness
Wed, September 7, 2011Tue, September 6, 2011Mon, September 5, 2011Sun, September 4, 2011Sat, September 3, 2011Fri, September 2, 2011Thu, September 1, 2011Wed, August 31, 2011Tue, August 30, 2011Mon, August 29, 2011Fri, August 26, 2011Thu, August 25, 2011Wed, August 24, 2011Tue, August 23, 2011Mon, August 22, 2011Sat, August 20, 2011Fri, August 19, 2011Thu, August 18, 2011Wed, August 17, 2011Tue, August 16, 2011Mon, August 15, 2011Fri, August 12, 2011Thu, August 11, 2011Wed, August 10, 2011Tue, August 9, 2011Mon, August 8, 2011Sun, August 7, 2011Sat, August 6, 2011Fri, August 5, 2011Thu, August 4, 2011Wed, August 3, 2011Tue, August 2, 20113SBio Inc. to Hold 2011 Annual General Meeting on September 20, 2011
Published in Health and Fitness on Saturday, August 20th 2011 at 9:46 GMT by Market Wire
3SBio Inc. to Hold 2011 Annual General Meeting on September 20, 2011 -- SHENYANG, China, Aug. 20, 2011 /PRNewswire-Asia-FirstCall/ --
3SBio Inc. to Hold 2011 Annual General Meeting on September 20, 2011
SHENYANG, China, Aug. 20, 2011 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (NASDAQ: [ SSRX ]) ("3SBio" or "Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that the annual general meeting of shareholders of 3SBio Inc. will be held on September 20, 2011 at 10:00 a.m., Shenyang time, at our executive office, 15/A-D, Huaxin International Tower, No. 219, Qingnian Ave., Shenhe District, Shenyang 110016, People's Republic of China. The shareholder record date is August 15, 2011.
3SBio has filed its annual report on Form 20-F with the audited financial statements for the fiscal year ended December 31, 20010, with the U.S. Securities and Exchange Commission (the "SEC"). 3SBio's annual report on Form 20-F can be accessed on the Investors section of the Company's website at [ http://www.3SBio.com ], as well as on the SEC's website at [ http://www.sec.gov ]. The materials related to the annual general meeting, including the notice of meeting, the proxy statement, and the voting card may also be accessed and downloaded at the Investors section of the Company website. Shareholders may request a hard copy of the above documents free of charge by contacting [ ir@3SBio.com ].
About 3SBio Inc.
3SBio is a leading, fully integrated, profitable biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China. Its focus is on addressing large markets with significant unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases. With headquarters and GMP-certified manufacturing facilities in Shenyang, PRC, 3SBio employs over 700 people. Shares trade in the form of American Depositary Shares (ADSs) on the NASDAQ stock market under the ticker symbol "SSRX". Please see [ www.3SBio.com ] for more information.
Investor Contacts
Bo Tan
Chief Financial Officer
3SBio Inc.
Tel: + 86 24 2581-1820
[ ir@3SBio.com ]
Tom Folinsbee
Director of Investor Relations
3SBio Inc.
Tel: + 852 8191-6991
[ ir@3SBio.com ]
SOURCE 3SBio Inc.
[ Back to top ] RELATED LINKS
[ http://www.3sbio.com ]
